Bayzed Health Group Inc (HKG:2609)

Bayzed Health Group Statistics

Total Valuation

HKG:2609 has a market cap or net worth of HKD 4.56 billion. The enterprise value is 4.40 billion.

Market Cap	4.56B
Enterprise Value	4.40B

Important Dates

The next estimated earnings date is Tuesday, May 26, 2026.

Earnings Date	May 26, 2026
Ex-Dividend Date	n/a

Share Statistics

HKG:2609 has 1.32 billion shares outstanding. The number of shares has increased by 11.23% in one year.

Current Share Class	1.32B
Shares Outstanding	1.32B
Shares Change (YoY)	+11.23%
Shares Change (QoQ)	+11.23%
Owned by Insiders (%)	51.75%
Owned by Institutions (%)	19.57%
Float	538.76M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	3.49
PB Ratio	2.55
P/TBV Ratio	6.43
P/FCF Ratio	29.80
P/OCF Ratio	22.94
PEG Ratio	n/a

Enterprise Valuation

The stock's EV/EBITDA ratio is 37.55, with an EV/FCF ratio of 28.72.

EV / Earnings	-135.87
EV / Sales	3.36
EV / EBITDA	37.55
EV / EBIT	192.71
EV / FCF	28.72

Financial Position

The company has a current ratio of 1.67, with a Debt / Equity ratio of 0.35.

Current Ratio	1.67
Quick Ratio	1.43
Debt / Equity	0.35
Debt / EBITDA	5.39
Debt / FCF	4.12
Interest Coverage	1.02

Financial Efficiency

Return on equity (ROE) is -1.18% and return on invested capital (ROIC) is -8.75%.

Return on Equity (ROE)	-1.18%
Return on Assets (ROA)	0.53%
Return on Invested Capital (ROIC)	-8.75%
Return on Capital Employed (ROCE)	1.09%
Weighted Average Cost of Capital (WACC)	n/a
Revenue Per Employee	620,837
Profits Per Employee	-15,372
Employee Count	2,105
Asset Turnover	0.49
Inventory Turnover	14.19

Taxes

In the past 12 months, HKG:2609 has paid 21.19 million in taxes.

Income Tax	21.19M
Effective Tax Rate	675.79%

Stock Price Statistics

Beta (5Y)	n/a
52-Week Price Change	n/a
50-Day Moving Average	4.01
200-Day Moving Average	n/a
Relative Strength Index (RSI)	35.87
Average Volume (20 Days)	4,970,460

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, HKG:2609 had revenue of HKD 1.31 billion and -32.36 million in losses. Loss per share was -0.02.

Revenue	1.31B
Gross Profit	237.02M
Operating Income	22.81M
Pretax Income	3.14M
Net Income	-32.36M
EBITDA	88.81M
EBIT	22.81M
Loss Per Share	-0.02

Balance Sheet

The company has 915.21 million in cash and 631.00 million in debt, with a net cash position of 284.21 million or 0.22 per share.

Cash & Cash Equivalents	915.21M
Total Debt	631.00M
Net Cash	284.21M
Net Cash Per Share	0.22
Equity (Book Value)	1.79B
Book Value Per Share	1.26
Working Capital	547.20M

Cash Flow

In the last 12 months, operating cash flow was 198.87 million and capital expenditures -45.80 million, giving a free cash flow of 153.07 million.

Operating Cash Flow	198.87M
Capital Expenditures	-45.80M
Free Cash Flow	153.07M
FCF Per Share	0.12

Margins

Gross margin is 18.14%, with operating and profit margins of 1.75% and -2.48%.

Gross Margin	18.14%
Operating Margin	1.75%
Pretax Margin	0.24%
Profit Margin	-2.48%
EBITDA Margin	6.80%
EBIT Margin	1.75%
FCF Margin	11.71%

Dividends & Yields

HKG:2609 does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-11.23%
Shareholder Yield	-11.23%
Earnings Yield	-0.71%
FCF Yield	3.36%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

HKG:2609 has an Altman Z-Score of 4.8 and a Piotroski F-Score of 5.

Altman Z-Score	4.8
Piotroski F-Score	5